title: Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.
abstract: Osteosarcoma is a genetically unstable malignancy that most frequently occurs in children and young adults. The lack of progress in managing this devastating disease in the clinic has prompted international researchers to collaborate to profile key genomic alterations that define osteosarcoma. A team of researchers and clinicians from China, Finland, and the United States investigated human osteosarcoma by integrating transcriptome sequencing (RNA-seq), high-density genome-wide array comparative genomic hybridization (aCGH), fluorescence in situ hybridization (FISH), reverse transcription-polymerase chain reaction (RT-PCR), Sanger sequencing, cell culture, and molecular biological approaches. Systematic analysis of genetic/genomic alterations and further functional studies have led to several important findings, including novel rearrangement hotspots, osteosarcoma-specific LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes, VEGF and Wnt signaling pathway alterations, deletion of the WWOX gene, and amplification of the APEX1 and RUNX2 genes. Importantly, these genetic events associate significantly with pathogenesis, prognosis, progression, and therapeutic activity in osteosarcoma, suggesting their potential impact on improved managements of human osteosarcoma. This international initiative provides opportunities for developing new treatment modalities to conquer osteosarcoma.
authors.affiliation: Departments of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, P. R. China. yangjilong@tjmuch.com.
authors.forename: Ji-Long
authors.initials: JL
authors.lastname: Yang
mesh_terms: D000328:Adult; D001859:Bone Neoplasms; D002648:Child; D002681:China; D055028:Comparative Genomic Hybridization; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase; D023281:Genomics; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D058990:Molecular Targeted Therapy; D012516:Osteosarcoma / Q000235:genetics* / Q000628:therapy*; D011379:Prognosis; D060449:Wnt Signaling Pathway; D055815:Young Adult
chemical_list: C085108:APEX1 protein, human; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase